These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20873363)

  • 1. Continuous subcutaneous insulin infusion in Type 1 diabetes: patient experiences of 'living with a machine'.
    Todres L; Keen S; Kerr D
    Diabet Med; 2010 Oct; 27(10):1201-4. PubMed ID: 20873363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Omnipod
    Polonsky WH; Hessler D; Layne JE; Zisser H
    Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes.
    Júlíusson PB; Graue M; Wentzel-Larsen T; Søvik O
    Acta Paediatr; 2006 Nov; 95(11):1481-7. PubMed ID: 17062481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Payk M; Robinson T; Davis D; Atchan M
    J Adv Nurs; 2018 Mar; 74(3):528-538. PubMed ID: 28960449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection.
    Franciosi M; Maione A; Pomili B; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E; Nicolucci A
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):7-14. PubMed ID: 19747804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review.
    Alsaleh FM; Smith FJ; Taylor KM
    J Clin Pharm Ther; 2012 Apr; 37(2):140-7. PubMed ID: 21729118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parents' experiences of managing their child's diabetes using an insulin pump: a qualitative study.
    Rankin D; Harden J; Noyes K; Waugh N; Barnard K; Lawton J
    Diabet Med; 2015 May; 32(5):627-34. PubMed ID: 25581347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
    Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
    Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of a 7 year case-control study of continuous intraperitoneal insulin infusion and subcutaneous insulin therapy among patients with poorly controlled type 1 diabetes mellitus: favourable effects on hypoglycaemic episodes.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Bilo HJ; Kleefstra N
    Diabetes Res Clin Pract; 2014 Nov; 106(2):256-63. PubMed ID: 25305134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey.
    Taleb N; Messier V; Ott-Braschi S; Ardilouze JL; Rabasa-Lhoret R
    Diabetes Res Clin Pract; 2018 Oct; 144():42-50. PubMed ID: 30077691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living with sensor-augmented pump therapy in type 1 diabetes: adolescents' and parents' search for harmony.
    Rashotte J; Tousignant K; Richardson C; Fothergill-Bourbonnais F; Nakhla MM; Olivier P; Lawson ML
    Can J Diabetes; 2014 Aug; 38(4):256-62. PubMed ID: 25023738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents.
    Alsaleh FM; Smith FJ; Thompson R; Al-Saleh MA; Taylor KM
    Int J Clin Pharm; 2014 Oct; 36(5):1023-30. PubMed ID: 25108411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.
    Thabit H; Hovorka R
    Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
    Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
    Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy.
    Indelicato L; Mariano V; Galasso S; Boscari F; Cipponeri E; Negri C; Frigo A; Avogaro A; Bonora E; Trombetta M; Bruttomesso D
    Diabet Med; 2017 May; 34(5):691-697. PubMed ID: 28145047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin pump therapy in children, adolescents and adults].
    Stadler M; Zlamal-Fortunat S; Schütz-Fuhrmann I; Rami-Merhar B; Fröhlich-Reiterer E; Hofer S; Mader J; Resl M; Kautzky-Willer A; Weitgasser R; Prager R; Bischof M
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S188-95. PubMed ID: 27052245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.